Integrated transcriptomic analysis and machine learning identify AURKA and CENPM as candidate biomarkers in focal segmental glomerulosclerosis
This study identified AURKA and CENPM as exploratory tissue-based candidate biomarkers for FSGS, with AURKA being the more robustly supported of the two; both require functional validation and independent confirmation before any therapeutic application can be considered.